Archives of Gynecology and Obstetrics

, Volume 287, Issue 3, pp 533–539 | Cite as

Female sexual dysfunction in Iran: study of prevalence and risk factors

  • Nahid Ghanbarzadeh
  • Mohammad Nadjafi-SemnaniEmail author
  • Mohammad-Reza Ghanbarzadeh
  • Ali Nadjfai-Semnani
  • Fatemeh Nadjfai-Semnani
General Gynecology



To assess the prevalence of and risk factors for female sexual dysfunction (FSD) among women in Birjand city, Iran.


This cross-sectional population-based survey was conducted in nine areas of Birjand, the provincial center of South Khorasan province and married women aged between 15 and 72 years were included. Data were collected by face-to-face interview and completing a self-administered questionnaire. FSD and related risk factors were assessed.


A total of 821 women with mean age of 31.5 ± 9.1 were studied. Of them, 694 (84.6 %) had active sexual relationship with their husband, 239 (29.1 %) had less than one intercourse per week, 320 (39 %) did not feel pleasure with their sexual activity and intercourse, 86 (10.5 %) had never attained an orgasm, 604 (73.6 %) had a highly satisfactory relationship with their husband.


Dissatisfaction and not feeling pleasure with sexual activity was the most common FSD in our study. Further epidemiologic investigation is clearly warranted.


Iran Female sexual dysfunction Female Epidemiology 



Authors would like to thank Dr. Kavian Ghandehri, Associate Professor of Neurology, Mashhad University of Medical Sciences, for reviewing the manuscript.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Safarinejad MR (2006) Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors. Int J Impot Res 18(4):382–395. doi: 10.1038/sj.ijir.3901440 PubMedCrossRefGoogle Scholar
  2. 2.
    Mayer ME, Bauer RM, Schorsch I, Sonnenberg JE, Stief CG, Uckert S (2007) Female sexual dysfunction: what’s new? Curr Opin Obstet Gynecol 19(6):536–540. doi: 10.1097/GCO.0b013e3282f1c73300001703-200712000-00006 PubMedCrossRefGoogle Scholar
  3. 3.
    Oksuz E, Malhan S (2006) Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol 175(2):654–658. doi: 10.1016/S0022-5347(05)00149-7 (discussion 658)PubMedCrossRefGoogle Scholar
  4. 4.
    Elnashar AM, El-Dien Ibrahim M, El-Desoky MM, Ali OM, El-Sayd Mohamed Hassan M (2007) Female sexual dysfunction in Lower Egypt. BJOG 114(2):201–206. doi: 10.1111/j.1471-0528.2006.01106.x PubMedCrossRefGoogle Scholar
  5. 5.
    Addis IB, Van Den Eeden SK, Wassel-Fyr CL, Vittinghoff E, Brown JS, Thom DH (2006) Sexual activity and function in middle-aged and older women. Obstet Gynecol 107(4):755–764. doi: 10.1097/01.AOG.0000202398.27428.e2 PubMedCrossRefGoogle Scholar
  6. 6.
    Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, Goldstein I, Graziottin A, Heiman J, Laan E, Leiblum S, Padma-Nathan H, Rosen R, Segraves K, Segraves RT, Shabsigh R, Sipski M, Wagner G, Whipple B (2000) Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 163(3):888–893 S0022-5347(05)67828-7[pii]PubMedCrossRefGoogle Scholar
  7. 7.
    Hayes RD, Bennett C, Dennerstein L, Gurrin L, Fairley C (2007) Modeling response rates in surveys of female sexual difficulty and dysfunction. J Sex Med 4(2):286–295. doi: 10.1111/j.1743-6109.2007.00433.x PubMedCrossRefGoogle Scholar
  8. 8.
    Dennerstein L, Lehert P (2004) Women’s sexual functioning, lifestyle, mid-age, and menopause in 12 European countries. Menopause 11(6 Pt 2):778–785 pii:00042192-200411061-00009PubMedCrossRefGoogle Scholar
  9. 9.
    Ponholzer A, Roehlich M, Racz U, Temml C, Madersbacher S (2005) Female sexual dysfunction in a healthy Austrian cohort: prevalence and risk factors. Eur Urol 47(3):366–374. discussion 374–365 doi: 10.1016/j.eururo.2004.10.005 PubMedCrossRefGoogle Scholar
  10. 10.
    Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’Agostino R Jr (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26(2):191–208. doi: 10.1080/009262300278597 PubMedCrossRefGoogle Scholar
  11. 11.
    Dalpiaz O, Kerschbaumer A, Mitterberger M, Pinggera GM, Colleselli D, Bartsch G, Strasser H (2008) Female sexual dysfunction: a new urogynaecological research field. BJU Int 101(6):717–721. doi: 10.1111/j.1464-410X.2007.07442.x PubMedCrossRefGoogle Scholar
  12. 12.
    Laumann EO, Paik A, Rosen RC (1999) Sexual dysfunction in the United States: prevalence and predictors. JAMA 281(6):537–544 pii:joc80785PubMedCrossRefGoogle Scholar
  13. 13.
    Oberg K, Fugl-Meyer AR, Fugl-Meyer KS (2004) On categorization and quantification of women’s sexual dysfunctions: an epidemiological approach. Int J Impot Res 16(3):261–269. doi: 10.1038/sj.ijir.3901151 PubMedCrossRefGoogle Scholar
  14. 14.
    Shokrollahi P, Mirmohamadi M, Mehrabi F, Babaei G (1999) Prevalence of sexual dysfunction in women seeking services at family planning centers in Tehran. J Sex Marital Ther 25(3):211–215. doi: 10.1080/00926239908403995 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Nahid Ghanbarzadeh
    • 1
  • Mohammad Nadjafi-Semnani
    • 2
    • 5
    Email author
  • Mohammad-Reza Ghanbarzadeh
    • 3
  • Ali Nadjfai-Semnani
    • 4
  • Fatemeh Nadjfai-Semnani
    • 4
  1. 1.Department of Gynecology and ObstetricsBirjand University of Medical UniversityBirjandIran
  2. 2.Department of UrologyBirjand University of Medical SciencesBirjandIran
  3. 3.Emergency Department of Qaem HospitalMashhad University of Medical SciencesMashhadIran
  4. 4.Tehran University of Medical SciencesTehranIran
  5. 5.BirjandIran

Personalised recommendations